FAIR VALUE MEASUREMENTS AND FINANCIAL INSTRUMENTS (Details) (USD $) In Millions, unless otherwise specified	Sep. 30, 2012	Dec. 31, 2011	Sep. 30, 2012 Fair Value on a Recurring Basis Level 1	Dec. 31, 2011 Fair Value on a Recurring Basis Level 1	Sep. 30, 2012 Fair Value on a Recurring Basis Level 2	Dec. 31, 2011 Fair Value on a Recurring Basis Level 2	Sep. 30, 2012 Fair Value on a Recurring Basis Total	Dec. 31, 2011 Fair Value on a Recurring Basis Total	Mar. 31, 2011 Fair Value on a Non-Recurring Basis Embrella Cardiovascular, Inc.
Fair value of financial instruments measured on a recurring basis
Investments held for executive deferred compensation plan			$ 12.5	$ 11.5			$ 12.5	$ 11.5
Investments in unconsolidated affiliates	2.6	3.3	2.6	3.3			2.6	3.3
Derivative assets					1.3	12.7	1.3	12.7
Total assets			15.1	14.8	1.3	12.7	16.4	27.5
Executive deferred compensation plan			12.0	9.9			12.0	9.9
Goodwill									34.6
Other Intangible Assets, net									$ 12.1